FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to oncology, and can be used in treatment of cancer. Methods involve administering an effective dose of cerium oxide nanoparticles (CONP) to a patient in combination with an irradiation and/or a chemotherapeutic agent.
EFFECT: use of the inventions enables higher clinical effectiveness ensured by increasing cancer cell sensitivity to radiation therapy by CONP, reduced dose of radiation therapy and chemotherapy, reduced toxicity associated with radiation therapy and chemotherapy.
25 cl, 4 tbl, 35 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF THERAPY FOR COLORECTAL CANCER IN IN VIVO EXPERIMENT | 2023 |
|
RU2814946C1 |
| COMBINATION AND METHODS FOR INTRODUCING THERAPEUTIC AGENTS AND COMBINED THERAPY | 2006 |
|
RU2452482C2 |
| TREATING PANCREATIC CANCER AND NON-SMALL CELL LUNG CANCER WITH ATR INHIBITORS | 2012 |
|
RU2648507C2 |
| COMBINED ANTICANCER THERAPY AND PHARMACEUTICAL COMPOSITIONS THEREFOR | 2005 |
|
RU2396960C2 |
| COMBINATIONS AND METHODS FOR ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY | 2013 |
|
RU2673805C2 |
| COMBINATIONS AND METHODS FOR THERAPEUTIC AGENTS INTRODUCTION AND COMBINED THERAPY | 2012 |
|
RU2632103C2 |
| ANTIBODIES AGAINST PD-1 FOR TREATMENT OF LUNG CANCER | 2018 |
|
RU2771759C2 |
| METHOD OF TREATING CANCER (VERSIONS) | 2006 |
|
RU2447889C2 |
| NANOPARTICLE, CONTAINING RAPAMYCIN AND ALBUMIN AS ANTI-CANCER AGENT | 2008 |
|
RU2483714C2 |
| NANOPARTICLE, CONTAINING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT | 2013 |
|
RU2678448C2 |
